Clinical Trial Update: Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [NA]

View source ↗

Summary

Status update on a clinical trial evaluating antithymocyte globulin and cyclosporine to prevent graft-versus-host disease in patients with acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | NA | Status: UNKNOWN